Clinical Trials Sponsored by Chiesi Foundation

Total 20939 results

PETHEMA Foundation

Active, not recruiting

Protocol GELLC-7: Ibrutinib Followed by Ibrutinib Consolidation in Combination With Ofatumumab

Chronic Lymphocytic Leukemia

Spain
PETHEMA Foundation

Completed

Clinical Trial to Assess the Efficacy and Toxicity of Induction and Consolidation With CPX-351 for Patients Aged 60 to 75 Years With Secondary or High-risk Acute Myeloid Leukemia (LAMVYX)

Newly Diagnosed Secondary or High Risk AML

Spain
COPD Foundation

Completed

Monitoring and Peer Support to Improve Treatment Adherence and Outcomes (O2VERLAP)

Chronic Obstructive Pulmonary Disease | Obstructive Sleep Apnea

United States
RILITE Foundation

Completed

Dynamic Imaging of Variation in Lupus Nephritis (DIVINE)

Lupus Nephritis

United States
Kovacs Foundation

Unknown

The Influence of Different Factors on Workers' Disability Due to Low Back Pain

Low Back Pain

Spain
Asan Foundation

Completed

Diagnostic Validity of [18F]FSPG PET for the Assessment of Disease Activity in Inflammatory Bowel Disease

Inflammatory Bowel Diseases | Crohn Disease | Ulcerative Colitis

Korea, Republic of
Kessler Foundation

Completed

Remediation of Emotional Processing Deficits in MS

Multiple Sclerosis

United States
Kessler Foundation

Completed

Remediation of Emotional Deficits in Multiple Sclerosis and Traumatic Brain Injury

Multiple Sclerosis | Traumatic Brain Injury

United States
PETHEMA Foundation

Completed

Selinexor (KPT-330) Plus FLAG-Ida for the Treatment of Relapsing/Refractory AML (FLAGINEXOR)

Acute Myeloid Leukemia

Spain
PETHEMA Foundation

Completed

CML Treated With Bosutinib After Relapse (BOSTRO)

Chronic Myeloblastic Leukaemia

Spain
PETHEMA Foundation

Completed

Treatment of Acute Lymphoblastic Leukemia HIGH RISK BCR / ABL NEGATIVE IN ADULTS

Acute Lymphoblastic Leukemia

Spain
PETHEMA Foundation

Completed

Pethema LAL-RI/2008: Treatment for Patients With Standard Risk Acute Lymphoblastic Leukemia

Acute Lymphobkastic Leukemia

Spain
EspeRare Foundation

Completed

Rimeporide in Patients With Duchenne Muscular Dystrophy (RIM4DMD)

Muscular Dystrophy, Duchenne

Italy, France, Spain, United Kingdom
Omphis Foundation

Completed

Study of Effectiveness of Pold in Chronic Nonspecific Low Back Pain (Pold-LBP)

Mechanical Low Back Pain

Spain
Omphis Foundation

Completed

Study of the Influence of Ductal Carcinoma in Situ on the Outcome of Invasive Breast Cancer

Outcome of Breast Cancer
Aspire Foundation

Completed

A Pilot Investigation Detecting Cryoablation Scar by 3D Late Gadolinium Enhancement (LAMDE)

Atrial Fibrillation | Cryoablation

United States
Kessler Foundation

Completed

Cogmed for Working Memory After TBI (Cogmed)

Traumatic Brain Injury

United States
PETHEMA Foundation

Completed

Lendexal in Patients With Primary Systemic Amyloidosis (AL) Newly Diagnosed (LENDEXAL)

Primary Systemic Amyloidosis

Spain
Lundbeck Foundation

Completed

Routine Bladder Catheterisation Through Fast-track Hip and Knee Replacement - What Are the Consequences?

Postoperative Urinary Retention

Denmark
Antea Foundation

Completed

Procedural Pain in Palliative Care: Prevalence, Intensity and Treatment

Pain | Cancer | Breakthrough Pain | Pain Due to Certain Specified Procedures | Terminal Disease

Italy
PETHEMA Foundation

Completed

Study of Induction Treatment With Velcade and Dexamethasone for Previously Untreated Patients With Multiple Myeloma and Renal Failure (RENVEL)

Multiple Myeloma

Spain
Maugeri Foundation

Completed

Sit-to-stand and Peripheral Muscle Strength in COPD

COPD

Italy
Kovacs Foundation

Completed

Association Between Neck Pain and Quality of Sleep

Disability | Chronic Neck Pain

Spain
Kovacs Foundation

Completed

Association Between Low Back Pain and Quality of Sleep

Depression | Disability | Quality of Sleep | Subacute or Chronic Low Back Pain | Catastrophizing

Spain
Kovacs Foundation

Completed

Prevalence of Low Back and Pelvic Pain in Pregnant Women

Low Back Pain | Pelvic Pain

Spain
PETHEMA Foundation

Completed

LAM07: Study to Analyze the Efficacy of a Risk Adapted Treatment Strategy, Including Gemtuzumab Ozogamicin (GO) During Consolidation, for Patients With Acute Myeloid Leukemia (AML)

Acute Myeloblastic Leukemia

Spain
Hubbard Foundation

Suspended

Multi-center Registry for CCSVI Testing and Treatment (CCSVI)

CCSVI | Chronic Cerebrospinal Venous Insufficiency | Venous Malformations of CNS Draining Veins

United States
PETHEMA Foundation

Completed

Bortezomib/Adriamycine/Melfalan/Prednisone (VAMP)/Thalidomide/Cyclophosphamide/Dexamethasone (TaCyDex) or Bortezomib/Melfalan/Prednisone (V-MP)/TaCyDex) in Refractary or Relapsed Multiple Myeloma (TaCyDexVMP7)

Multiple Myeloma

Spain
Kovacs Foundation

Terminated

World Health Organization Disability Assessment Schedule II (WHODAS-II) for Patients With Symptomatic Lumbar Spinal Stenosis

Lumbar Spinal Stenosis

Spain
Kessler Foundation

Unknown

Validation of an Obstacle Course Used in Patients With Muscle Tightness

Stroke | Multiple Sclerosis | Traumatic Brain Injury | Spasticity | Healthy Controls

United States
AB Foundation

Completed

Miltefosine (Long Course) for Bolivian Mucosal Leishmaniasis

Leishmaniasis

Bolivia
PETHEMA Foundation

Completed

LAL-Ph-2000: Treatment of Acute Lymphoblastic Leukemia Chromosome Philadelphia Positive

Acute Lymphoblastic Leukemia

Spain
Kovacs Foundation

Completed

Active Management for Low Back Pain for 6 to 8 Year Old Schoolchildren

Low Back Pain

Spain
PETHEMA Foundation

Completed

TAMOVALCIR in Allogenic Hematopoietic Progenitors Transplant

Cytomegalovirus Infection

Spain
PETHEMA Foundation

Completed

GEM05 for Patients With Multiple Myeloma Under 65 Years (GEM05MENOS65)

Multiple Myeloma

Spain
PETHEMA Foundation

Completed

PETHEMA LAL-RI/96: Treatment for Patients With Standard Risk Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia

Spain
PETHEMA Foundation

Completed

Glivec® (Imatinib Mesylate, STI571) in Monotherapy Versus Glivec®-Interferon Alpha in the Treatment of Chronic-Phase Chronic Myeloid Leukaemia

Chronic Myeloid Leukaemia

Spain
PETHEMA Foundation

Completed

Glivec in Ph Positive Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia | Cromosome Philadelphia Positive

Spain
Kessler Foundation

Unknown

Adjusting Wheelchair Set-Up to Minimize Shoulder Joint Forces During Propulsion

Paraplegia | Upper Limb Pain

United States
PETHEMA Foundation

Completed

Treatment of Acute Promyelocytic Leukemia With All-Trans Retinoic Acid (ATRA) and Idarubicin (AIDA)

Acute Promyelocytic Leukemia

Spain
AB Foundation

Completed

Miltefosine for Mucosal Leishmaniasis

Leishmaniasis

Bolivia
Westfälische Wilhelms-Universität Münster
Chiesi GmbH

Recruiting

German Observational Multicenter Study of Patients With Fabry Disease Under Enzyme Replacement Therapy With Pegunigalsidase-alfa (GoPEG)

Fabry Disease

Germany
University of Parma
Chiesi Farmaceutici S.p.A.

Not yet recruiting

Effect of BDP/Formoterol/G on Cough Efficacy in Moderate to Severe COPD Patients (EFFICACE) (EFFICACE)

COPD, Chronic Obstructive Pulmonary Disease

Italy
Baylor Research Institute
Chiesi USA, Inc.

Recruiting

Management of Antiplatelet Regimen During Surgical Procedures (MARS)

Surgery | Cardiac Surgery | Surgery--Complications | Percutaneous Coronary Intervention

United States
Nantes University Hospital
Chiesi Farmaceutici S.p.A.

Completed

PK Study in Diabetic Transplant récipients : From Twice-daily Tacrolimus to Once-daily Extended-release Tacrolimus (SPK-PK)

Diabetes | Kidney Transplantation | Pancreas Transplantation

France
Chiesi UK
Gesellschaft für Therapieforschung mbH

Active, not recruiting

A Trial Monitoring Therapy Pathways of Asthma Patients Treated With an Extrafine ICS/LABA/LAMA Single-inhaler Triple Therapy in a Real-world Setting and Characterizing the Effects on Health-related Out-comes (TriMaximize)

Asthma

United Kingdom
Thomas Jefferson University
Chiesi Farmaceutici S.p.A.

Completed

Buprenorphine Pharmacometric Open Label Research Study of Drug Exposure (B-PHORE)

Neonatal Abstinence Syndrome | Neonatal Opiate Withdrawal Syndrome

United States
Zymenex A/S

Completed

Porphozym in the Treatment of Acute Attacks in AIP

Acute Intermittent Porphyria

United States
UniQure Biopharma B.V.
Chiesi Farmaceutici S.p.A.

Withdrawn

Alipogene Tiparvovec for the Treatment of LPLD Patients

LPL Deficiency

Canada, United States
NorthShore University HealthSystem
Chiesi USA, Inc.

Recruiting

Prophylactic Minimally Invasive Surfactant Evaluation (PreProMISe)

Premature Birth | Respiratory Distress Syndrome, Newborn

United States

3

Subscribe